Turnstone Biologics, Corp.
5 clinical trials · Sponsor
◉ Watch Turnstone Biologics, Corp.
| Record | Firm | Date |
|---|---|---|
| A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors (NCT05576077) | Turnstone Biologics, Corp. | 2023-01-17 |
| Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors (NCT04301011) | Turnstone Biologics, Corp. | 2020-06-02 |
| MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneous Squamous Cell Carcinoma (NCT03773744) | Turnstone Biologics, Corp. | 2020-02-15 |
| This is a Trial of MG1-E6E7 With Ad-E6E7 and Atezolizumab in Patients With HPV Associated Cancers (NCT03618953) | Turnstone Biologics, Corp. | 2018-06-21 |
Track Turnstone Biologics, Corp. automatically
Every clearance here is in the API, with alerts when new ones post.